Related Articles
Tyrosine kinase inhibitors in breast cancer (Review)
Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma (Review)
The advance of the third‑generation EGFR‑TKI in the treatment of non‑small cell lung cancer (Review)
Targeted therapy in HER2‑positive breast cancer (Review)
Cardiotoxicity of anthracycline‑free targeted oncological therapies in HER2‑positive breast cancer (Review)